Literature DB >> 31222636

Cytokine Response in the Pleural Fluid and Blood in Minimally Invasive and Open Esophagectomy.

T Delko1, D I Watson1, B Beck-Schimmer2, A Immanuel1, D J Hussey1, U Zingg3,4.   

Abstract

BACKGROUND: Transthoracic esophagectomy for cancer triggers a massive inflammatory reaction. The data whether a minimally invasive esophagectomy (MIE) leads to less pronounced inflammatory response compared to open right-sided transthoracic esophagectomy (OE) are scarce. The aim of this study was to evaluate the extent of the inflammatory reaction, represented by levels of the pro-inflammatory interleukins IL-6 and IL-8, the anti-inflammatory IL-1 RA and the chemokines CINC-1 and MCP-1 in the right pleural fluid and the blood from patients undergoing standard OE or MIE.
METHODS: Pleural drainage fluid and blood was collected at five different time points during the first 72 h following surgery, and the concentrations of IL-6, IL-8, IL-1 RA, CINC-1 and MCP-1 were analyzed using enzyme-linked immune-sorbent assays in 24 patients undergoing MIE or OE.
RESULTS: The groups were matched for cancer stage and comorbidities. Pro- and anti-inflammatory mediator levels in the pleural fluid were markedly increased at the end of surgery and on postoperative days 1-3. The pleural inflammatory response of all cyto- and chemokines was lower in the MIE group, reaching significance at some time points. Cyto- and chemokine response levels measured in the blood were overall lower compared to those in the pleural fluid. The chemokines CINC-1 and MCP-1 reacted less pronounced or not at all. Preoperative pulmonary comorbidity, postoperative pulmonary morbidity and length of surgery were associated with an increased reaction in selected mediators.
CONCLUSIONS: The minimally invasive technique attenuates the inflammatory response, especially locally in the thoracic compartment. Length of procedure, preoperative pulmonary comorbidity and postoperative pulmonary complications are mirrored in an increase in individual inflammatory markers in the pleural fluid. The value of the chemokines CINC-1 and MCP-1 as markers of inflammation in the setting of esophagectomy is unclear.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31222636     DOI: 10.1007/s00268-019-05069-w

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  33 in total

1.  Activation of monocytes and endothelial cells depends on the severity of surgical stress.

Authors:  S Aosasa; S Ono; H Mochizuki; H Tsujimoto; S Osada; E Takayama; S Seki; H Hiraide
Journal:  World J Surg       Date:  2000-01       Impact factor: 3.352

Review 2.  Comparison of laparoscopy-assisted by conventional open distal gastrectomy and extraperigastric lymph node dissection in early gastric cancer.

Authors:  Min-Chan Kim; Ki-Han Kim; Hyung-Ho Kim; Ghap-Joong Jung
Journal:  J Surg Oncol       Date:  2005-07-01       Impact factor: 3.454

Review 3.  Sex differences in immune responses.

Authors:  Sabra L Klein; Katie L Flanagan
Journal:  Nat Rev Immunol       Date:  2016-08-22       Impact factor: 53.106

4.  Inflammatory response in ventilated left and collapsed right lungs, serum and pleural fluid, in transthoracic esophagectomy for cancer.

Authors:  Urs Zingg; Jens Forberger; Daniel M Frey; Adrian J Esterman; Daniel Oertli; Beatrice Beck-Schimmer; Andreas Zollinger
Journal:  Eur Cytokine Netw       Date:  2010-03       Impact factor: 2.737

Review 5.  Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review.

Authors:  David G Watt; Paul G Horgan; Donald C McMillan
Journal:  Surgery       Date:  2015-02       Impact factor: 3.982

6.  The geriatric cytokine response to trauma: time to consider a new threshold.

Authors:  Mary E Ottinger; Sean F Monaghan; Stefan Gravenstein; William G Cioffi; Alfred Ayala; Daithi S Heffernan
Journal:  Surg Infect (Larchmt)       Date:  2014-12       Impact factor: 2.150

7.  Elevation of circulating interleukin 6 after surgery: factors influencing the serum level.

Authors:  K Sakamoto; H Arakawa; S Mita; T Ishiko; S Ikei; H Egami; S Hisano; M Ogawa
Journal:  Cytokine       Date:  1994-03       Impact factor: 3.861

Review 8.  Systematic review of outcomes used to evaluate enhanced recovery after surgery.

Authors:  A Neville; L Lee; I Antonescu; N E Mayo; M C Vassiliou; G M Fried; L S Feldman
Journal:  Br J Surg       Date:  2014-02       Impact factor: 6.939

Review 9.  Reducing hospital morbidity and mortality following esophagectomy.

Authors:  B Zane Atkins; Ashish S Shah; Kelley A Hutcheson; Jennifer H Mangum; Theodore N Pappas; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

10.  Serum interleukin-6, interleukin-8, hepatocyte growth factor, and nitric oxide changes during thoracic surgery.

Authors:  T Yamada; M Hisanaga; Y Nakajima; H Kanehiro; A Watanabe; T Ohyama; K Nishio; M Sho; M Nagao; A Harada; K Matsushima; H Nakano
Journal:  World J Surg       Date:  1998-08       Impact factor: 3.352

View more
  2 in total

1.  A retrospective study of preoperative malnutrition based on the Controlling Nutritional Status score as an associated marker for short-term outcomes after open and minimally invasive esophagectomy for esophageal cancer.

Authors:  Tomo Horinouchi; Naoya Yoshida; Kazuto Harada; Kojiro Eto; Hiroshi Sawayama; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Yuji Miyamoto; Hideo Baba
Journal:  Langenbecks Arch Surg       Date:  2022-08-17       Impact factor: 2.895

2.  Impact of Minimally Invasive Esophagectomy in Post-Operative Atrial Fibrillation and Long-Term Mortality in Patients Among Esophageal Cancer.

Authors:  LaiTe Chen; BinBin Li; ChenYang Jiang; GuoSheng Fu
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.